B
MRNA icon

Birchbrook’s Moderna MRNA Stock Holding History

Birchbrook’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28K Hold
400
– – 0.01% 155
2026
Q1 		$20.3K Hold
400
– – 0.01% 161
2025
Q4 		$11.8K Hold
400
– – 0.01% 197
2025
Q3 		$10.3K Hold
400
– – 0.01% 190
2025
Q2 		$11K Hold
400
– – 0.01% 188
2025
Q1 		$11.3K Hold
400
– – 0.01% 180
2024
Q4 		$16.6K Hold
400
– – 0.01% 177
2024
Q3 		$26.7K Sell
400
-200
-33% -$18.4K 0.01% 141
2024
Q2 		$71.3K Hold
600
– – 0.04% 106
2024
Q1 		$63.9K Hold
600
– – 0.04% 111
2023
Q4 		$59.7K Buy
+600
New +$50.5K 0.04% 111

Other funds holding MRNA

BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
TFCP
Twin Focus Capital Partners Boston, Massachusetts $983M AUM 37.07% 1-Year Est. Return

Birchbrook's MRNA Position: Q2 2026 in Review

Birchbrook held its Moderna (MRNA) position steady in Q2 2026 at 400 shares worth $28K. The position accounts for 0.01% of the portfolio, ranked #155.

Birchbrook first reported a position in MRNA in Q4 2023 and has held it in 11 quarters since. The position peaked at $71.3K in Q2 2024. 283 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Birchbrook held 400 shares of Moderna worth $28K as of Q2 2026.
  • Birchbrook left its Moderna share count unchanged in Q2 2026.
  • Moderna made up 0.01% of Birchbrook's portfolio in Q2 2026, its #155 holding.
  • Birchbrook first reported a position in Moderna in Q4 2023 and has held it in 11 quarters since.
  • Birchbrook's Moderna position peaked at $71.3K in Q2 2024.
  • 283 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Birchbrook's 13F filing for Q2 2026, filed 9 Jul 2026.